Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 43% ± 24% | |
microglial cell | 6 studies | 28% ± 8% | |
macrophage | 6 studies | 41% ± 28% | |
GABAergic neuron | 6 studies | 38% ± 19% | |
oligodendrocyte precursor cell | 5 studies | 30% ± 7% | |
interneuron | 5 studies | 35% ± 20% | |
neuron | 4 studies | 23% ± 7% | |
endothelial cell | 4 studies | 24% ± 10% | |
epithelial cell | 4 studies | 21% ± 3% | |
monocyte | 4 studies | 39% ± 34% | |
astrocyte | 4 studies | 26% ± 7% | |
oligodendrocyte | 4 studies | 22% ± 4% | |
alveolar macrophage | 3 studies | 26% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2395.31 | 2641 / 2642 | 100% | 37.65 | 705 / 705 |
ovary | 100% | 1596.43 | 180 / 180 | 100% | 27.44 | 429 / 430 |
esophagus | 100% | 1823.04 | 1445 / 1445 | 99% | 27.18 | 182 / 183 |
breast | 100% | 1270.57 | 458 / 459 | 100% | 37.25 | 1114 / 1118 |
prostate | 100% | 1775.70 | 245 / 245 | 99% | 24.17 | 499 / 502 |
lung | 100% | 1882.98 | 576 / 578 | 100% | 22.33 | 1150 / 1155 |
thymus | 100% | 2057.81 | 653 / 653 | 99% | 23.94 | 599 / 605 |
kidney | 100% | 2052.64 | 89 / 89 | 98% | 25.11 | 884 / 901 |
pancreas | 99% | 962.45 | 326 / 328 | 98% | 17.52 | 175 / 178 |
stomach | 100% | 1348.29 | 359 / 359 | 97% | 23.88 | 278 / 286 |
intestine | 100% | 1739.24 | 966 / 966 | 97% | 19.43 | 511 / 527 |
liver | 100% | 1261.89 | 226 / 226 | 97% | 18.77 | 393 / 406 |
uterus | 100% | 1465.45 | 170 / 170 | 97% | 18.81 | 444 / 459 |
bladder | 100% | 1682.90 | 21 / 21 | 97% | 17.80 | 487 / 504 |
skin | 99% | 992.17 | 1795 / 1809 | 93% | 21.45 | 438 / 472 |
adrenal gland | 100% | 1676.65 | 258 / 258 | 88% | 10.80 | 202 / 230 |
spleen | 100% | 2243.84 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.36 | 1 / 1 |
blood vessel | 100% | 1573.35 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1189.74 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 6019.17 | 927 / 929 | 0% | 0 | 0 / 0 |
muscle | 100% | 1272.66 | 799 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.44 | 44 / 45 |
heart | 93% | 1176.38 | 805 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 11.92 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 83% | 16.49 | 66 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061025 | Biological process | membrane fusion |
GO_0046604 | Biological process | positive regulation of mitotic centrosome separation |
GO_0007030 | Biological process | Golgi organization |
GO_0000132 | Biological process | establishment of mitotic spindle orientation |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_1904780 | Biological process | negative regulation of protein localization to centrosome |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000045 | Biological process | autophagosome assembly |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0031616 | Cellular component | spindle pole centrosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005634 | Cellular component | nucleus |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | UBXN2B |
Protein name | UBX domain protein 2B UBX domain-containing protein 2B (NSFL1 cofactor p37) (p97 cofactor p37) |
Synonyms | |
Description | FUNCTION: Adapter protein required for Golgi and endoplasmic reticulum biogenesis . Involved in Golgi and endoplasmic reticulum maintenance during interphase and in their reassembly at the end of mitosis . The complex formed with VCP has membrane fusion activity; membrane fusion activity requires USO1-GOLGA2 tethering and BET1L . VCPIP1 is also required, but not its deubiquitinating activity . Together with NSFL1C/p47, regulates the centrosomal levels of kinase AURKA/Aurora A during mitotic progression by promoting AURKA removal from centrosomes in prophase . Also, regulates spindle orientation during mitosis . . |
Accessions | ENST00000521796.1 E5RJ36 Q14CS0 ENST00000399598.7 E5RGJ4 ENST00000520732.5 ENST00000523409.5 H0YAX6 |